Open AccessMK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis inob/obmice
Author(s) -
Tatsuya Ohyama,
Ken Sato,
Yuichi Yamazaki,
Hiroaki Hashizume,
Norio Horiguchi,
Satoru Kakizaki,
Masatomo Mori,
Motoyasu Kusano,
Masanobu Yamada
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i43.16227
Subject(s) - medicine , endocrinology , steatosis , chemistry , triglyceride , fatty acid synthase , fatty liver , lipid metabolism , cholesterol , disease
To investigate the mechanism and in vivo effects of MK-0626, a dipeptidyl peptidase-4 inhibitor, on hepatic steatosis using ob/ob mice.